Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

Sentinel Cerebral Protection System Reduces TAVR Strokes More Than 60 Percent
News | Embolic Protection Devices | May 08, 2018

May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of...

Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong

The European interventional cardiology market is currently valued at nearly $1.4 billion. This is a mature market...

Videos | Cath Lab | May 07, 2018

Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs...

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.

 

Feature | Antiplatelet and Anticoagulation Therapies | May 07, 2018

May 7, 2018 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first...

An 3D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.

A 3-D echo view of a Neovasc Tiara transcatheter mitral valve. This valve is currently in clinical trials and is ahead of most of the TMVR devices in development.

Feature | Heart Valve Technology | May 04, 2018 | Dave Fornell, Editor

May 4, 2018 — Transcatheter...

The Medtronic In.Pact Admiral Paclitaxel-coated (DCB) Percutaneous Transluminal Angioplasty Balloon Catheter is now indicated for lesions up to 360 mm in length.
Technology | Drug-Eluting Balloons | May 03, 2018

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has expanded the indication for the Medtronic In.Pact ...

Technology | Intravascular Imaging | May 02, 2018

May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy - Cardioband Tricuspid Valve Reconstruction System
News | Heart Valve Technology | May 01, 2018

May 1, 2018 — Edwards Lifesciences Corp.announced that it received CE Mark for the Edwards Cardioband Tricuspid...

Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions. Shockwave Medical technology uses sonic bursts to break up calcium in coronary arteries.

The article "Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions" was the most popular article posted on the DAIC website in April. Shockwave Medical's technology uses sonic bursts to break up calcium in coronary arteries without vessel trauma associated with angioplasty or atherectomy. 

Feature | May 01, 2018 | Dave Fornell, Editor

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC)...

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment. The treatment is also called sclerotherapy.

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment.

Feature | Venous Therapies | April 30, 2018 | Tif Siragusa, M.D.

The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a...

Intact Vascular Announces $20 Million Series C Financing
News | Stents Peripheral | April 27, 2018

April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is...

HeartFlow FFRct Analysis Added to ITP Payment Program in the U.K.
News | FFR Technologies | April 25, 2018

April 25, 2018 — HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow...

Emboline Inc. Completes Funding for TAVR Embolic Protection Trial
News | Embolic Protection Devices | April 20, 2018

April 20, 2018 — Emerging medical device company Emboline Inc. announced it has completed a Series B funding round...

A CT scan assessment of the femoral access route challenges for a recent Central DuPage Hospital TAVR candidate. This image and the measurements were discussed by the heart team during its weekly meeting to determine if the TAVR delivery catheters could navigate the disease femoral artery and what options might best serve this patient.

A CT scan assessment of the femoral access route challenges for a recent Central DuPage Hospital TAVR candidate. This image and the measurements were discussed by the heart team during its weekly meeting to determine if the TAVR delivery catheters could navigate the disease femoral artery and what options might best serve this patient. 

 

Feature | Heart Valve Technology | April 20, 2018 | Dave Fornell

While there is fear by many about the trend of hospitals consolidating into larger healthcare systems, one advantage...

360 Photos | Cath Lab | April 20, 2018

A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located...

Overlay Init